TSCAN THERAPEUTICS INC

Ticker: TCRX CUSIP: 89854M101 Class: Common Stock

Lynx1 Capital Management LP's Holding History (CIK: 0001910456)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 8,019,148 Value ($000) $8,019 Avg Close $1.45 Range $0.88 - $2.57
Q3 2025
Shares 7,857,347 Value ($000) $14,300 Avg Close $1.77 Range $1.43 - $1.99
Q2 2025
Shares 7,857,347 Value ($000) $11,393 Avg Close $1.44 Range $1.02 - $1.87
Q1 2025
Shares 5,357,347 Value ($000) $7,393 Avg Close $2.16 Range $1.28 - $3.21
Q4 2024
Shares 5,357,347 Value ($000) $16,286 Avg Close $4.53 Range $2.60 - $6.22
Q3 2024
Shares 5,224,600 Value ($000) $26,019 Avg Close $6.03 Range $4.90 - $7.89
Q2 2024
Shares 5,224,600 Value ($000) $30,564 Avg Close $7.88 Range $5.60 - $9.69
Q1 2024
Shares 5,224,600 Value ($000) $41,483 Avg Close $6.29 Range $4.64 - $9.00
Q4 2023
Shares 5,224,600 Value ($000) $30,459 Avg Close $4.58 Range $2.43 - $7.15
Q3 2023
Shares 5,224,600 Value ($000) $13,375 Avg Close $2.33 Range $1.93 - $3.04
Q2 2023
Shares 5,224,600 Value ($000) $13,062 Avg Close $2.68 Range $1.62 - $6.03